Response to the Letter to the Editor "When sacubitril/valsartan met neprilysin and B-type natriuretic peptide in the labyrinth of biochemistry"

Rev Port Cardiol (Engl Ed). 2020 Mar;39(3):179-180. doi: 10.1016/j.repc.2020.03.010. Epub 2020 May 4.

[Article in English, Portuguese]

Authors

Cândida Fonseca¹, Dulce Brito², Jorge Ferreira², Fátima Franco², João Morais², José Silva Cardoso²

Affiliations

¹ Clínica de Insuficiência cardíaca, Hospital São Francisco Xavier - Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal. Electronic address: mcandidafonseca@gmail.com.
² Clínica de Insuficiência cardíaca, Hospital São Francisco Xavier - Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal.

PMID: 32370992
DOI: 10.1016/j.repc.2020.03.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Aminobutyrates
Biphenyl Compounds
Drug Combinations
Natriuretic Peptide, Brain
Neprilysin*
Tetrazoles
Valsartan

Substances

Aminobutyrates
Biphenyl Compounds
Drug Combinations
Tetrazoles
Natriuretic Peptide, Brain
Valsartan
Neprilysin
sacubitril and valsartan sodium hydrate drug combination